
OpenEvidence is a leading medical information platform that organizes and expands the world's medical knowledge. Launched from the Mayo Clinic Platform Accelerate program and featuring content from The New England Journal of Medicine and JAMA, it aims to solve the challenge of medical information overload for physicians, researchers, and healthcare professionals. OpenEvidence aggregates, synthesizes, and visualizes clinically relevant evidence to support evidence-based decision-making and improve patient outcomes. The platform is free for verified U.S. healthcare professionals and is trusted by over 10,000 care centers. The company has strong investor backing from prominent firms like Sequoia Capital and Google Ventures and has achieved significant milestones, including being named to Forbes' AI 50 list and achieving a top score on the USMLE.

OpenEvidence is a leading medical information platform that organizes and expands the world's medical knowledge. Launched from the Mayo Clinic Platform Accelerate program and featuring content from The New England Journal of Medicine and JAMA, it aims to solve the challenge of medical information overload for physicians, researchers, and healthcare professionals. OpenEvidence aggregates, synthesizes, and visualizes clinically relevant evidence to support evidence-based decision-making and improve patient outcomes. The platform is free for verified U.S. healthcare professionals and is trusted by over 10,000 care centers. The company has strong investor backing from prominent firms like Sequoia Capital and Google Ventures and has achieved significant milestones, including being named to Forbes' AI 50 list and achieving a top score on the USMLE.
Founded: 2017
Industry: Biomedical / Biotechnology (AI/NLP)
Headquarters: Wilmington, Delaware, United States
Funding: Seed round (Jan 1, 2019); investor: Xfund
Medical/biomedical information extraction and synthesis using AI/NLP to support clinicians and researchers.
2017
Biotechnology